IMO. Today's price and volume action suggests Arafura is lifting on the back of LYC's positive performance.(of which I am also a holder)
However I do share the bullish sentiment going forward, essentially because ARU has a very high relative % of heavy REE's compared to LYC or MolyCorp, for which both Demand and price remain firm (relative to Light REE's)
The technical's also suggest ARU has bottomed. This is a fallen stock in terms of s.price but it's NPV value is a multiple of the current share price. The stock is still being accumulated by smart money. I have finished buying a month ago.
The above is my opinion only, based on my research, and in line with my risk profile. It is not my intention to influence anyone else. My holdinds is a long term position with a 4-7 year view.
Cheers
Huckle
- Forums
- ASX - By Stock
- trade entry
IMO. Today's price and volume action suggests Arafura is lifting...
-
- There are more pages in this discussion • 3 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ARU (ASX) to my watchlist
|
|||||
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $450.5M |
Open | High | Low | Value | Volume |
19.5¢ | 20.0¢ | 19.0¢ | $534.1K | 2.745M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 631081 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 91095 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 450450 | 0.190 |
36 | 1402850 | 0.185 |
52 | 2950448 | 0.180 |
33 | 1999047 | 0.175 |
42 | 4385432 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 91095 | 2 |
0.200 | 1253164 | 11 |
0.205 | 1037792 | 19 |
0.210 | 2285685 | 23 |
0.215 | 548767 | 13 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
ARU (ASX) Chart |